# Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers

> **NCT04251819** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 19 (actual)

## Conditions studied

- Acute Pain
- Analgesia

## Interventions

- **DRUG:** Placebos
- **DRUG:** Baclofen 5 mg
- **DRUG:** Baclofen 10mg

## Key facts

- **NCT ID:** NCT04251819
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-21
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-06-15
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** No funding for this project
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04251819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04251819, "Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04251819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*